Matrix Metalloproteinase-3 Joins a Growing List of Proteases That Regulate Vascular Calcification

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2024 Apr 17

PMID 38630897

Authors

Cecilia Maria Giachelli

Maristella Donato

Marta Scatena

Affiliations

Soon will be listed here.

Citing Articles

Gallic acid: a dietary metabolite's therapeutic potential in the management of atherosclerotic cardiovascular disease.

Zhao X, Cao Z, Li K, Tang F, Xu L, Zhang J Front Pharmacol. 2025; 15():1515172.

PMID: 39840111 PMC: 11747375. DOI: 10.3389/fphar.2024.1515172.

References

Hecht E, Freise C, Websky K, Nasser H, Kretzschmar N, Stawowy P . The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant. 2015; 31(5):789-97. DOI: 10.1093/ndt/gfv321. View

Qin X, Corriere M, Matrisian L, Guzman R . Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol. 2006; 26(7):1510-6. DOI: 10.1161/01.ATV.0000225807.76419.a7. View

Provenzano M, Andreucci M, Garofalo C, Faga T, Michael A, Ielapi N . The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?. Biomolecules. 2020; 10(1). PMC: 7022805. DOI: 10.3390/biom10010154. View

Xie Y, Lin T, Jin Y, Berezowitz A, Wang X, Lu J . Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification. Cardiovasc Res. 2024; 120(6):658-670. PMC: 11074797. DOI: 10.1093/cvr/cvae035. View

Andrault P, Panwar P, Mackenzie N, Bromme D . Elastolytic activity of cysteine cathepsins K, S, and V promotes vascular calcification. Sci Rep. 2019; 9(1):9682. PMC: 6609650. DOI: 10.1038/s41598-019-45918-1. View

Wu T, Leu H, Lin W, Lin C, Lin S, Chen J . Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur J Clin Invest. 2005; 35(9):537-45. DOI: 10.1111/j.1365-2362.2005.01548.x. View

Hosaka N, Mizobuchi M, Ogata H, Kumata C, Kondo F, Koiwa F . Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int. 2009; 85(6):523-9. DOI: 10.1007/s00223-009-9297-8. View

Guizani I, Zidi W, Zayani Y, Nesrine F, Douik H, Sanhaji H . Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study. Mol Biol Rep. 2022; 49(10):9171-9179. DOI: 10.1007/s11033-022-07742-1. View

Matilla L, Roncal C, Ibarrola J, Arrieta V, Garcia-Pena A, Fernandez-Celis A . A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis. Arterioscler Thromb Vasc Biol. 2020; 40(5):1370-1382. DOI: 10.1161/ATVBAHA.120.314143. View

10.

Pai A, Leaf E, El-Abbadi M, Giachelli C . Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011; 178(2):764-73. PMC: 3069837. DOI: 10.1016/j.ajpath.2010.10.006. View